The synthesis of complex organic molecules is at the heart of modern pharmaceutical development. Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylate, known by its CAS number 144689-93-0, exemplifies the precision required in producing key pharmaceutical intermediates. This compound is a critical precursor for Olmesartan Medoxomil, a drug essential for managing high blood pressure, making its efficient and pure synthesis a priority for chemical manufacturers.

At NINGBO INNO PHARMCHEM CO., LTD., the production of this imidazole derivative synthesis is a carefully orchestrated process. It involves precise control over reaction conditions to achieve the target molecule with minimal impurities. The quality of this intermediate directly influences the entire Olmesartan Medoxomil intermediate synthesis process. Achieving high purity, often reported as 99% or more, is a testament to advanced chemical engineering and quality control measures.

Researchers and chemists often seek detailed information on the CAS 144689-93-0 properties. This includes understanding its molecular formula (C12H20N2O3) and molecular weight (240.3 g/mol), which are fundamental for stoichiometric calculations in subsequent reactions. The compound's physical form, typically a white powder, also plays a role in its handling and processing in industrial settings.

The demand for high-quality API intermediate compounds like this one is driven by the global need for effective cardiovascular treatments. Pharmaceutical companies rely on specialized chemical suppliers for consistent and reliable access to these building blocks. The ability to procure such materials with guaranteed purity and timely delivery is crucial for maintaining production schedules and ensuring market supply.

Beyond its direct use, this compound is also valuable in understanding pharmaceutical synthesis pathways and potential side reactions. Studying its behavior and the formation of related impurities, such as those associated with Olmesartan, contributes to the overall optimization of drug manufacturing processes. This analytical aspect is vital for regulatory compliance and continuous improvement in drug quality.

As a significant player in the field of drug discovery building blocks, NINGBO INNO PHARMCHEM CO., LTD. is dedicated to advancing the synthesis and supply of critical intermediates. The meticulous production of Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylate highlights their commitment to chemical excellence and their contribution to the pharmaceutical industry's ability to deliver life-saving medications.